WebMD Announces Third Quarter Financi... (September 30 September 30 ...)

WebMD Announces Third Quarter Financial Results

Date:11/3/2009

September 30, September 30, ------------- -------------- 2009 2008 2009 2008 ---- ---- ---- ---- Revenue Public portal advertising and sponsorship $89,414 $74,658 $232,695 $197,523 Private portal services 22,154 22,139 67,768 65,928 ------ ------ ------ ------ $111,568 $96,797 $300,463 $263,451 ======== ======= ======== ======== Earnings before interest, taxes, non-cash and other items ("Adjusted EBITDA") (a) $33,123 $25,467 $75,029 $60,191 ------- ------- ------- ------- Adjusted EBITDA per basic common share $0.57 $0.44 $1.30 $1.04 ----- ----- ----- ----- Adjusted EBITDA per diluted common share $0.56 $0.43 $1.28 $1.04 ----- ----- ----- ----- Interest, taxes, non-cash and other items (b) Interest income 834 2,616 2,733 8,419 Depreciation and amortization (6,988) (7,056) (20,729) (20,815) Non-cash advertising - (178) (1,753) (1,736) Non-cash stock-based compensation (5,746) (3,512) (17,021) (10,657) Impairment of auction rate securities - - - (27,406) Income tax provision (8,622) (7,375) (15,469) (15,308) ------ ------ ------- ------- Income (loss) from continuing operations

SOURCE WebMD
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Related medicine news :

1. FDA and WebMD Expand Consumer Health Information Partnership
2. WebMD to Present at the Canaccord Adams 29th Annual Global Growth Conference
3. WebMD Announces Second Quarter Financial Results
4. WebMD Launches Free Mobile Application For Physicians
5. HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call
6. HLTH Corporation and WebMD Health Corp. Announce Agreement to Merge
7. WebMD to Present at Jefferies 3rd Annual Healthcare Conference
8. COPD Foundation announces launch of Lung Health Check on WebMD
9. HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call
10. WebMD Announces Strategic Relationship with Boots UK to Launch New Consumer Health Portal in UK
11. WebMD to Present at the Morgan Stanley Technology Conference

Post Your Comments:

(Date:12/1/2009)...ewswire-USNewswire/ -- The following is being rele...ent: ,, Chairman Kerry, Ranking Member Lugar, a... be nominated by President Obama to serve as Admin...onal Development, and I appreciate his confidence ...e Clinton has expressed the conviction that, along...

(Date:12/1/2009)...hority Encourages Older Persons and Healthcare Wor... Based Upon Authority Data ,, HARRISBURG, Pa.... of all vaccine preventable deaths occur in those ..., according to highlighted studies in the Pennsylv...ient Safety Advisory . ,, According to the Cent...

(Date:12/1/2009)...rforming surgical operations without leaving scars...ty. This is demonstrated by the recent surgical ad...nal Endoscopy Surgery), an innovative surgical app... natural orifices. The results are all advantageou... stay and faster recovery. Currently, this type of...

(Date:12/1/2009)...ness declines with age are more likely to engage i...heir misguided negative view of the aging process ... encourage them to make the most of the present in...ngs 1 by Dr. John Garry and Dr. Maria Lohan from ...published online in Springer,s Journal of Happine...

(Date:12/1/2009)...iversit de Montral researcher, funded by the Inter...d Violence Against Women, has launched a new study... started our research seeking men in their twentie...find any," says Simon Louis Lajeunesse, a postdoct... Work. , "The objective of my work is to observ...

[0] Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 [1] Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory [0] Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus [0] Binge drinking youths find getting old a drag [0] Are the effects of pornography negligible?

...N, Mass., Aug. 5 Indevus,Pharmaceuticals, Inc. (N...sults of operations for the third quarter ended Ju...ll and webcast today beginning at 9:00 am,eastern ...quarter ended June 30,2008. This compares to reven...

... Allsup explains the pros, cons ...owing a long-term disabling event, especially duri...ce benefits , Belleville,...use of a disability, according to http://allsup.c...

... Cenegenics® Medical Institu...nnounced the opening of Cenegenics Indiana. The c...hing over 2008-2009. The new Cenegenics Indiana wi...ptured global media attention, such as 60 Minutes,...

... QHR client hospital Gritman Med...st, Pullman Regional Hospital, were recently ranke...re and Medicaid Services (CMS) in "overall pa...n physician recruitment and share medical equipmen...

... The rapid growth in popularity ...ny skeptics wrong. A recent poll shows that the b...umers, privacy concerns. From dating, through gen... Carlsbad, Calif. (PRWEB) August 5, 2...

...BEACH, Calif., Aug. 5 Today the United States,Pat...ronmentally "Green",low cost process that eliminat...g oxidants. The patent includes methods for abatin... processes,there is a significant increase in effi...

Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results Ten Questions to Ask When Considering COBRA Following a Disability Global Leader In Age Management Announces New Indiana Medical Center Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal USPTO Issues Patent Embodying Methodologies for Abating a Broad Range of Allergens, Pathogens, Viruses, Bacteria, Odors and Volatile Organic Compounds.

(Date:12/1/2009)..., , MINNETONKA, Minn., Dec. 1 /PRNewswire/...ology solutions company specializing in clinical s...IGHTEN ®, its industry-leading EDC/eClinical ...nical Data Interchange Standards Consortium (CDISC...M) standard. This certification underscores MedNe...

(Date:12/1/2009)..., , CAMBRIDGE, Mass. and TOKYO, Dec. 1 /PR...al Co., Ltd. announced today the further extension...hrough 2011. This latest extension increases the ...otal committed funding to approximately $90 millio... January 2005 with the goal of discovering and dev...

(Date:12/1/2009)..., , CLEARWATER, Fla., Dec. 1 /PRNewswire/ ...provider of medical supplies, today announced that...ankruptcy Court for District of Delaware (the "Cou... the marketing and proposed sale of substantially ...d November 24, 2009, the Court approved bidding pr...

Breaking Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2 Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2 Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3 CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2 Evolution of a contraceptive for sea lamprey 8994 1 Evolution of a contraceptive for sea lamprey 8994 2 AAHSA Statement on House Ways and Means Committee Hearing 49988 1 AAHSA Statement on House Ways and Means Committee Hearing 49988 2 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 1 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 2 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 3 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 4

[0] MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification [0] Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration [0] CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures

...ecting Devastating Genetic Diseases -, PHILADELPH...ell connected to other areas, researchers successf...in -- after one injection of,gene therapy. If thes...earchers may have a potential method for gene ther...ital human neurological disorders, such as,Tay-Sac...

...eutics, Inc., a,privately-held biopharmaceutical c...ation of proprietary compounds to treat gastrointe...has completed the patient enrollment,of its Phase ...al,double-blind, placebo controlled study, FHAST1 ...to determine the efficacy and safety of oral,AST-1...

Other Medicine Technology:One Shot of Gene Therapy Spreads Through Brain in Animal Study 2 One Shot of Gene Therapy Spreads Through Brain in Animal Study 3 Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohn's Disease 2 Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohn's Disease 3

One Shot of Gene Therapy Spreads Through Brain in Animal Study Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohn's Disease

...channel within a 12.1mm insertion tube. It featur...d image for improved reliability, an electronic be...5 and 5.0mhz transducer for deeper ultrasound imag...ical orientation and vascular evaluation during re...

...of diagnosis by using the Convex Scanning method. ...od flow by using the Color Flow Mapping and Color ...rated and the balloon fixation has improved. Those...curate techniques. The FG-36UX expands the possibi...

ACL 1000 Coagulation Analyzer

SYNCHRON CX®5 Delta

Medicine Products:

Linear Endoscope Ultrasound (EG-3630U)Linear Endoscope Ultrasound (FG-36Ux)ACL 1000 Coagulation Analyzer SYNCHRON CX®5 Delta

WebMD Announces Third Quarter Financi...(September 30 September 30 ...),Health